image
117 S. Cook St. #353
Barrington, IL 60010
Phone: 
(847) 304-0333    
Fax:
(847) 304-4440
Mobile: 
     

Publications       

  

  [ back to main Curriculum Vitae page | download publications (PDF) ]

  1. Standardized Total Parenteral Nutrition Formula. I.V.Topics Infusion 1:1 September,1976.
  2. Pharmacy Based Special Infant Formula Service. American Journal of Hospital Pharmacy 33:1018-1020 (Oct,1976).
  3. Pharmacy Assisted Skin Bank Program. American Journal of Hospital Pharmacy 34:1353-1354, (Dec) 1977.
  4. Increasing the Awareness of the Consultant Pharmacist to the Use of Therapeutic Nutritional Products. Contemporary Writing in Long Term Pharmacy. 1:1, 78-85, (Oct) 1978. American Society of Consultant Pharmacists, Alexandria, VA.
  5. Patient Prescription Information. Consultant/Author/Editor. Chicago, IL 1978.
  6. Essential Trace Elements. Lyphomed Nutritional Newsletter. Vol. l No. l, Chicago, IL. November, 1980.
  7. Total Parenteral Nutrition and the Pharmacist. Illinois Journal of Pharmacy Vol. 42 No. 3,27-32 (March,1980).
  8. Drug Regulatory Issues and Their Effect on Parenteral Vitamin Marketing. Lyphomed Nutritional Newsletter. Vol. l No. 2, Chicago, IL. (Feb) 1981.
  9. Drug Regulatory Issues and Their Effect on Parenteral Vitamin Marketing. Illinois Journal of Pharmacy Vol. 43 No. 5, (May, 1981).
  10. Significant Drug Nutrient Interactions. Lyphomed Nutritional Newsletter. Vol.1 No. 3, Chicago, IL. May,1981.
  11. Drug Regulatory Issues and Their Effect on Parenteral Vitamin Marketing Infusion. Vol. 5 No. 3, (May) 1981.
  12. Intravenous Potassium Administration and Therapeutic Guidelines. Infusion. Vol. 5 No. 4, p.89 (July-August) 1981.
  13. Continuing Controversy on Intravenous Diazepam and Phenytoin Administration. Infusion. Vol. 5 No. 5, p.122 (Sept/Oct) 1981.
  14. Vitamin K Intravenous Administration, Indications, Adverse Reactions, and Contraindications. Infusion. Vol. 5 No. 6,154-155, (Nov/Dec) 1981.
  15. Standardized Parenteral Nutrition Solutions. Lyphomed Nutritional Newsletter. Vol. 2 No. l, Chicago, IL. Winter, 1981.
  16. Significant Drug Nutrient Interactions for the Pharmacist. Illinois Journal of Pharmacy Vol. 44 No.2,10-11, (Feb) 1982.
  17. Intravenous Insulin in the Diabetic Surgical Patient. Infusion. Vol. 6 No. 2, p. 48-50, March/ April,1982.
  18. Intravenous Nitroglycerin: Use and Special Administration Consideration. Infusion. Vol. 6 No. 3, p. 89-90 May/June, 1982.
  19. Compatibility of Critical Care Drugs: Where is the information? Infusion. Vol. 6 No. 4, p. 118-120. July, 1982.
  20. Selenium. Lyphomed Nutritional Newsletter Vol. 2 No. 3, Chicago Summer,1982.
  21. Effect of Light on Vitamin Stability in IV Solutions. Lyphomed Nutritional Newsletter Vol. 2 No. 4, Chicago, Fall,1982.
  22. Light Sensitivity of Intravenous Drugs. Infusion. Vol. 6 No. 5, p.155-156, Sept/Oct,1982.
  23. Molybdenum. Lyphomed Nutritional Newsletter Vol. 3 No.1, Chicago, December,1982.
  24. Antibiotic Prophylaxis in Surgical Infection. Heart and Lung. Vol.12 No.1. pp 20-22. Jan.1983.
  25. Cardioplegia Infusion. Vol. 7 No.1, Jan/Feb,1983.
  26. Selenium. Gastroenterology. March, 1983. (Letter to Editor).
  27. Selenium and Molybdenum. Therapeutic Newsletter. Rush Presbyterian-St. Luke's Medical Center, Chicago, IL. March, 1983.
  28. Selenium and Molybdenum. New Trace Elements for Intravenous Additive use. Infusion. Vol. 7 No. 2. Mar/Apr, 1983.
  29. Chymopapain: A New Therapeutic Agent. Infusion. Vol. 7 No.3, June/July,1983.
  30. Vasopressin-Intravenous Administration Guidelines. Infusion. Vol. 7 No.4, Aug/Sept,1983.
  31. Electrolytes in Parenteral Nutrition. Lyphomed Nutritional Newsletter. Vol.3 No.2, Summer,1983.
  32. Guidelines for Extravasation of Intravenous Drugs. Infusion. Vol. 7 No.4, Sept/Oct,1983.
  33. Selenium in Total Parenteral Nutrition: Clinical Experience in Two Medical Centers. (Editor) Lyphomed Inc Chicago, December,1983.
  34. Intravascular Lidocaine-Proceed with Caution. Infusion. Vol.8 No. l, Jan/Feb,1984.
  35. Trace Elements, Past, Present and Future. Lyphomed Nutritional Newsletter. Vol.3 No.2, Spring,1984.
  36. Quality Assurance for Hospital Pharmacy Strategies and Techniques. Legal Aspects of Medical Practices. (Book Review) Vol.12 No.6, Pharmaceutical Communications Inc, Long Island City, NY June,1984.
  37. Pharmacy Malpractice: An Avoidable Hospital Cost. Perspective in Pharmacy Vol. l, No.2, MacMillan Professional Journals, Chicago, IL. (June) 1984.
  38. Guidelines for Compatibility of IV Additives. Infusion. Vol.8 No.3, June/July,1984.
  39. Toxicity and Allergenicity of Antimicrobial Preservatives in Parenteral Products. Lyphomed Nutritional Newsletter. Vol.4, No. l, Summer,1984.
  40. Nursing Guidelines for Critical Care Drug Compatibility. Nursing 84. Vol.14, No. 11 November,1984.
  41. White Paper Users Evaluation of Mini-Infusion Devices. Associated Pharmacist Consultants, Inverness, IL. 1984,1985.
  42. Lidocaine Use in Placing IV Cannula's, Journal of The National Intravenous Therapy Association. Vol. 8, No.1, 69-71. Jan/Feb 1985.
  43. In Support of Mandatory Continuing Education for Pharmacists. Illinois Pharmacist March, 1985. (letter).
  44. Controlling Costs Through Old and New Methods. Editorial. Perspectives in Pharmacy. Vol. 2, No. 2, Spring 1985, MacMillan Professional Journals, Chicago, IL.
  45. Regional Compounding Facilities. A New Arena of Pharmacy Practice. Perspectives in Pharmacy. Vol.2, No.2, Spring 1985, MacMillan Professional Journals, Chicago, IL.
  46. Drug Injuries Resulting in Malpractice Suits. Malpractice Newsletter. NY April 1985.
  47. Introduction to Adverse Drug Reactions. Infusion, Vol. 9 July,1985 p.112-115.
  48. Monitoring and Reporting Adverse Drug Reactions. (Editorial) Infusion, Nov/Dec,1985.
  49. Toxicity and Deficiency of Micronutrients in a TPN Patient. Lyphomed Nutritional Newsletter, Vol. 5 Number 3,1985.
  50. Is Pharmacy Malpractice an Avoidable Cost? Florida Journal of Hospital Pharmacy, Vol.5, July, 1985, p. 35-59.
  51. Nursing Management of Drug Nutrient Interactions. Nursing 86 February 1986.
  52. Iron Toxicity, Treatment and a Case of Iatrogenic Poisoning. Infusion, Vol. 10, Number 1, Jan.1986.
  53. The Role of The Clinical Pharmacist in Risk Management. Topics in Hospital Pharmacy Management, Vol. 6 No.2, 37-45. Aug.1986.
  54. Medication Review Form for Assessing the Developmentally Disabled. The Consultant Pharmacist 1986, p. 86 (Letter).
  55. Aminoglycoside Ototoxicity (editorial). Infusion, Vol. 10, No.3,1986. pp.52-57.
  56. Analysis of Hospital Pharmacy Pricing Methods in the 305 Area Code Region (Greater Miami). Florida Journal of Hospital Pharmacy 7(1):1-9, January,1987.
  57. The Toxicity and Allergenicity of Antimicrobial Preservatives in Parenteral Pharmaceuticals. Infusion, Vol. 101, No. 6,1987,100-104.
  58. Monoclonal Antibodies-Orthoclone OKT. Infusion. Vol. 11, No. 5,1987. pp. 77-79.
  59. Protamine Adverse Reactions. Infusion, Vol. 11, No.1,1987,11-12.
  60. Introduction to Adverse Drug Reactions. New Jersey Trial Lawyers Journal, Fall,1987.
  61. The Role of the Clinical Pharmacist in Risk Management. Florida Journal of Hospital Pharmacy, 8(1):47-55, January,1988.
  62. Clinical Pharmacists Role in Risk Management. New Jersey Trial Lawyers Journal, April, 1988.
  63. History of Development of Standards of Practice for the Profession of Pharmacy. Journal of Pharmacy Practice, 1(1), August,1988.
  64. Status of Standards of Practice for the Profession of Pharmacy. Journal of Pharmacy Practice, 1(1). August,1988.
  65. Developing HiTech Pharmacy Services for Home Care. CARING, September,1988.
  66. Nutrition Fraud. Journal of Pharmacy Practice, 1(2), October,1988.
  67. Drugs in Pregnancy and Lactation. Journal of Pharmacy Practice, 2(1), February,1989.
  68. Adverse Effects of Steroids. Journal of Pharmacy Practice. 2(4), August,1989.
  69. Court Backs Right to Refuse Psychotropics. Drug Topics (Hospital Pharmacist Report) (Sept Suppl), 21-22,1989.
  70. Motion Sickness drug use in delivery comes under fire. Drug Topics Suppl (Hospital Pharmacy Report). (Nov Suppl) 1989.
  71. Status of Standards of Practice in Pharmacy. Safety Brief, Vol 5. No 4. January 1990. Triodyne, Inc. Niles, IL.
  72. Injuries From Drugs. AmJur 7, Proof of Facts 3d , 1-142./1990. (Chapter) Bancroft Whitney, San Francisco, CA.
  73. Can patients be forced to take mind-altering drugs. Drug Topics Suppl (Hospital Pharmacy Report). (May Suppl) 1990.
  74. Faulty cardioplegia solution leads to $492,000 verdict. Drug Topics Suppl (Hospital Pharmacy Report). (Aug Suppl) 1990.
  75. Status of Standards of Practice in Pharmacy. National Trial Lawyer April 1990, pp 37-50.
  76. Magnesium Overdose Kills Pregnant R.Ph. Her Twins Saved. Drug Topics Suppl (Hospital Pharmacy Report).134:11-12 (Nov Suppl) 1990.
  77. Beware of Charcoal/Sorbitol to treat Theophylline poisoning. Drug Topics Suppl (Hospital Pharmacy Report). (Nov Suppl) 1990.
  78. Hospital Pharmacist Negligence contributes to multimillion dollar settlement. Drug Topics Suppl (Hospital Pharmacy Report).1,22, (Dec Suppl) 1990.
  79. Pain Equilibration-Making It Understandable for the Jury. National Trial Lawyer, January,1991.
  80. Wisconsin Pharmacists Found Negligent for dispensing Silver nitrate. Drug Topics Suppl (Hospital Pharmacy Report). March 1991.
  81. Does Fetal Risk Justify Banning Women from Chemo Prep? Drug Topics Suppl (Hospital Pharmacy Report). May 1991.
  82. Michigan Court Rules Pharmacists have no duty to warn. Drug Topics Suppl (Hospital Pharmacy Report). (Jun Suppl) 1991.
  83. Drug Therapy in Pregnancy and Lactation. National Trial Lawyer, July 1991, pp. 81-88.
  84. Pharmacist error suggested in baby's brain damage. Drug Topics Suppl (Hospital Pharmacy Report). (Sept Suppl) 1991.
  85. Tennessee Suit R.Ph.s can be judged against practice standards. Drug Topics Suppl (Hospital Pharmacy Report). December 1991.
  86. Anaphylactic Reaction to Cefazolin in a Penicillin Allergic Patient. Drug Topics Suppl. (Hospital Pharmacist Report) (Oct Suppl) 1991.
  87. Parallax error is linked to AZT hospital mixup. Drug Topics Suppl (Hospital Pharmacy Report). Vol 6 No 1 (Jan Suppl) 1992.
  88. Theophylline in Litigation. Journal of the Association of Food and Drug Officials. Vol 56 No 1 January, 1992. 43-52.
  89. Steroid Rxs and 'p.r.n' can mean legal trouble. Drug Topics. Vol 136, No 1, 46. January 1992.
  90. "If you warn, do it right", judge tells pharmacists. Drug Topics, Vol 134, No 35-36. February 1992.
  91. Coumadin Rx Error results in $722,500 Verdict. Drug Topics, March,1992.
  92. $60 million in damages sought in insulin cover-up suit. Drug Topics Suppl (Hospital Pharmacy Report). Vol 6 No 4:1,8 (Apr Suppl) 1992.
  93. New Legal Landmine: Forced use of Psychotropics. Drug Topics Suppl (Hospital Pharmacy Report). Vol 6 No 6:30 (Jun Suppl) 1992.
  94. Theophylline Injuries Resulting in Litigation. Journal of Pharmacy Practice. Vol V No 4 (August) 1992.
  95. Clinical Pharmacist Sued as Negligent Investigator. Drug Topics Suppl (Hospital Pharmacy Report). Vol 6 No 11 (Nov Suppl) 1992.
  96. Chain lands in hot water over aspirin allergy case. Drug Topics 136;22:72,74 November 1992.
  97. Understanding Adverse Drug Reactions. NURSING 92. August 1992.
  98. Hypoglycemic Adverse Reactions to Insulin and Sulfonylureas, Journal of Pharmacy Practice, Vol V, No 5 (October),1992: pp 300-310.
  99. Understanding Adverse Drug Reactions, MED ERRORS Nursing 93, January, 1993.
  100. Should Parolee be forced to take Psychotropic Drugs? Drug Topics Suppl (Hospital Pharmacy Report). 134:11-12 (Jan Suppl) 1993.
  101. Hospital Sued for Not Giving Rescue Drug. Drug Topics Suppl (Hospital Pharmacy Report). Vol. 7, No.1, (January),1993. p 29.
  102. Understanding Adverse Drug Reactions. Safety Brief, Vol 8, No 2, March 1993. Triodyne,Inc Niles, IL.
  103. Licenses Threatened in Digoxin Death. Drug Topics Suppl. (Hospital Pharmacy Report). Vol. 7, No. 3, (March),1993. p 32.
  104. Missouri Hospital Settles Second Cardioplegia Death Suit. Drug Topics Suppl. (Hospital Pharmacy Report) Vol. 7, No. 4, (April), 1993, pp 1,11.
  105. Guidelines for Critical Care Drug Compatibility-Update 1993. Nursing 93. July,1993.
  106. Understanding Theophylline Malpractice. The Malpractice Reporter, NY NY Volume 12, Numbers 7 & 8, July, 1993.
  107. Cardioplegia Litigation and Recommendations Journal of Pharmacy Practice, Vol. Vl, No. 4 (August), 1993:pp 151-152.
  108. Court finds manufacturer not guilty in lidocaine mix-up. Drug Topics Suppl (Hospital Pharmacy Report). November,1993. Vol 7, #11.
  109. Pharmacist's Use of Abbreviations Alleged to Cause Codeine Death. Lippincott's Hospital Pharmacy. July, 1993 (in press).
  110. CHAPTER Insulin and Sulfonylurea Hypoglycemic Injuries. Legal Medicine 1993. Butterworth Legal Publications.
  111. Predictions in Drug Therapy (Ed). Nursing 94, March,1994.
  112. Theophylline Misadventures I. Neonatal Network, The Journal of Neonatal Nursing, March, 1994.
  113. Theophylline Misadventures II. Neonatal Network, The Journal of Neonatal Nursing, April 1994.
  114. OR Pharmacists Warned to Keep Tight Rein Over Ketamine. Drug Topics Suppl (Hospital Pharmacy Report). (Jan Suppl) 1994.
  115. Suit Against Hospital, Caremark Stresses Need for Communication. Drug Topics Suppl. (Hospital Pharmacy Report). Vol. 8, No. 3, (March),1994. p. 58.
  116. Alcohol: Gastrointestinal and Other Toxicities. Journal of Pharmacy Practice, Vol. VI, No. 4 (August),1994; pp 196-208.
  117. Understanding the Dangers of Neuromuscular Blockers. Drug Alert. Critical Care 94. Nursing 94. December,1994, 32BB.
  118. CHAPTER Adverse Drug Reactions. Legal Medicine 1994, Wecht CH. Editor. Butterworth, Salem, NH. p 229-267.
  119. Benign Substances Aren't Always Benign (Sodium Chloride Toxicity). Drug Alert. Critical Care 95. Nursing 95. February, 95.
  120. Respiratory Depression. Drug Alert. Critical Care 95. Nursing 95, April,1995. 32JJ.
  121. BOOK Moch J, Borja A, and O’Donnell JT. Eds. Pharmacy Law Litigating Pharmaceutical Cases. Lawyers & Judges Publishing Company, Tucson, AZ. May,1995.
  122. CHAPTER. Adverse Drug Reactions; Extent of the Problem and Causality Assessment. In Moch J, Borja A, and O’Donnell JT. Eds. Pharmacy Law Litigating Pharmaceutical Cases. Lawyers & Judges Publishing Company, Tucson, AZ. May,1995.(57 - 92).
  123. CHAPTER. Theophylline. The Unpredictively Toxic Asthma Drug. In Moch J, Borja A, and O’Donnell JT. Eds. Pharmacy Law Litigating Pharmaceutical Cases. Lawyers & Judges Publishing Company, Tucson, AZ. May,1995.(161 - 190).
  124. CHAPTER. O’Donnell JT and Tortoriello P. Steroids Effect and Regulation. In Moch J, Borja A, and O’Donnell JT. Eds. Pharmacy Law Litigating Pharmaceutical Cases. Lawyers & Judges Publishing Company, Tucson, AZ. May,1995.(213 - 270).
  125. CHAPTER. O’Donnell JT. Hypoglycemic Adverse Reactions to Insullin and Sulfonylureas. Moch J, Borja A, and O’Donnell JT. Eds. Pharmacy Law Litigating Pharmaceutical Cases. Lawyers & Judges Publishing Company, Tucson, AZ. May,1995.(271 - 301).
  126. CHAPTER. Borja A, Moch J, and O’Donnell JT. The Pharmacist. Moch J, Borja A, and O’Donnell JT. Eds. Pharmacy Law Litigating Pharmaceutical Cases. Lawyers & Judges Publishing Company, Tucson, AZ. May,1995.(301 - 337).
  127. CHAPTER. Borja A, Moch J, and O’Donnell JT. Eds. Taking the Pharmacist Malpractice Case to Trial. Moch J, Borja A, and O’Donnell JT. Pharmacy Law Litigating Pharmaceutical Cases. Lawyers & Judges Publishing Company, Tucson, AZ. May,1995.(5349 -377).
  128. CHAPTER. O’Donnell JT. Pain Equilibration. In, Moch J, Borja A, and O’Donnell JT. Eds. Pharmacy Law Litigating Pharmaceutical Cases. Lawyers & Judges Publishing Company, Tucson, AZ. May,1995.(409 - 426).
  129. Avoiding Vasopressor Extravasation. Drug Alert. Critical Care 95. Nursing 95. June,1995. 32X.
  130. Understanding Alcohol Tests. Chicago Daily Law Bulletin. Professional Litigation Services Directory. Summer 1995. p 10,16.
  131. Theophylline Toxicity. Drug Alert. Critical Care 95. Nursing 95, August,1995. 32Y.
  132. Chemical and Physical Restraints in Elderly Patients. Journal of Pharmacy Practice, Vol. IX No. 2, (April), 1996.
  133. CHAPTER. Medication Errors. In Nursing Malpractice, Iyer P. Ed. Lawyers & Judges Publishing Company, Tucson, AZ. May,1996.
  134. Medication Error Misadventures. Journal of Pharmacy Practice, Vol IX, No. 3 (June) 1996, pp 167 - 180.
  135. Cardiopulmonary Adverse Effects of Oral and Subcutaneous Terbutaline for Tocolysis. Journal of Pharmacy Practice, Vol. IX, No 3 (June) 1996, pp181 - 187.
  136. Corticosteroid Misadventures. Journal of Pharmacy Practice, Vol IX, No. 3 (June) 1996, pp.203 -215.
  137. Diets and Obesity Drug Treatment. Journal of Pharmacy Practice, Vol IX, No. 5 (October) 1996, pp 330 - 341.
  138. Anabolic Steroids: Effects and Regulation Journal of Pharmacy Practice. Vol IX, No 5 (October) 1996, pp 313 - 329.
  139. Vitamins, Minerals, and Nutritional Supplements Journal of Pharmacy Practice. Vol IX, No. 5 (October) 1996. pp 342 - 359.
  140. Performance Enhancing Drug Use in Athletes, Journal of Pharmacy Practice Vol IX, No. 5 (October) 1996. pp 386 -395.
  141. Pharmacists' Responsibilities in Sports and Fitness. Journal of Pharmacy Practice, Vol IX, No. 5 (October) 1996, pp 297 - 299.
  142. Medical Dangers of Tobacco Use, Journal of Pharmacy Practice, Vol. X, No. 5,October 1997, 316-325.
  143. Bromocriptine Induced Life-threatening Dysrhythmia . American Journal of Therapeutics, vol 5, No. 2 March, 1998, 111-115.
  144. Diet Drug Disaster: The Story of Redux and Fen-Phen. Journal of Pharmacy Practice, Vol. XI, No. 2/April 1998, 81-112.
  145. Diets and Obesity Drug Treatment. Journal of Pharmacy Practice, Vol. XI, No. 2/April 1998, 113-124.
  146. Pharmacotherapy of Chronic Nonmalignant Pain. Journal of Pharmacy Practice, Vol. XI, No.5, October, 1998. 374-381.
  147. Etanercept (Enbrel) - Drug of the Month Monograph. Department of Pharmacology Web Page. Rush Medical College, Chicago, IL. (www.rushu.rush.edu/pharm/dept/), April, 1999.
  148. (Interviewed for) Water R. Precarious Prescriptions; Can your doctor’s prescriptions hurt you? Salon Magazine, http://www.salonmagazine.com/health/feature/1999/05/05/prescriptions/ May 5, 1999.
  149. Withdrawal from Calcium Channel Blockers in a pregnant woman, American Journal of Therapeutics, Vol 6, No. 1, January 1999, 61-66.
  150. KPBS Public Radio. Metabolife (Dangers of Ephedrine). San Diego, CA 8/31/99. http://www.kpbs.org/radio/content_programs_news_storylist.html
  151. Drug Induced Hepatotoxicity. Journal of Pharmacy Practice, Vol XII, No. 6/ December1999. 443-461.
  152. Propylene Glycol Pediatric Neurotoxicity: Dangers of Diluents. Case Report and Literature Review. Journal of Pharmacy Practice, Vol XIII, No. 3/June 2000, 214-225.
  153. Forensic Pharmacist Report in a Coumadin Death Case. Journal of Pharmacy Practice, Vol XIII, No. 3, June, 2000, 236-245.
  154. Specific forensic Applications for Pharmacists. Journal of Pharmacy Practice, Vol XIII, No. 3, June 2000, 187-193.
  155. Farewell. (Editorial). Journal of Pharmacy Practice, Vol XIII, No. 3, June 2000, 173-175.
  156. BOOK Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishing Company, Tucson, AZ., 2000.
  157. CHAPTER 6, Adverse Drug Reactions and Causality Assessment in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ, 2000.
  158. CHAPTER 7B, Diet Drugs, Redux and Fen-Phen Two Points of View, Fen-Phen and Redux: Lessons Learned, Serotonin Chemistry, Anorexigenic Pharmacology/Interactions/ Cautions in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ., 2000.
  159. CHAPTER 12, Theophylline: The Unpredictable Toxic Asthma Drug in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ., 2000.
  160. CHAPTER 13, Corticosteroids in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ., 2000.
  161. CHAPTER 14, Adverse Effects of Diabetic Drugs in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ., 2000.
  162. CHAPTER 15, Drug Induced Hepatotoxicity in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ., 2000.
  163. CHAPTER 17, Pain Medications in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ., 2000.
  164. CHAPTER 19, Performance Enhancing Drugs: Anabolic Steroids and Dietary Supplements/Ephedrine in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ., 2000.
  165. CHAPTER 20, Recreational Drugs in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ., 2000.
  166. CHAPTER 21, The Pharmacist in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ., 2000.
  167. CHAPTER 26, The Forensic Pharmacist in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ. , 2000.
  168. CHAPTER 30, Medication Errors in O’Donnell JT, Drug Injury: Liability, Analysis, and Prevention. Lawyers & Judges Publishers Tucson, AZ., 2000.
  169. Drug Induced Esophagitis: Case Reports and Literature Review. Journal of Pharmacy Practice. Vol IX, No. 4, August, 2000.
  170. CHAPTER. Medication Errors. In Nursing Malpractice, Second Edition, Iyer P. Ed. Lawyers & Judges Publishing Company, Tucson, AZ., 2001.
  171. (Interviewed for) Ghristie T. Deadly side effects? Suicides cast suspicion on acne drug. Http//www.registerguard.com/news/200109301/1a.accutanegreufe.0930.html
  172. Overview of Existing Research And Information Linking Accutane (Isotretinoin), Depression, Psychosis And Suicide. Hearing Proceedings: Accutane-Is This Acne Drug Treatment Linked to depression and Suicide? Committee on Government Reform, One Hundred Sixth Congress, Second Session, Serial No. 106-248. U.S. Government Printing Office.73 924 DTP, pp. 71-96.
  173. (Interviewed for) Vedantam, S. Plane Crash Revives Accutane Questions: Pilot Had Prescription for Acne Medication Linked to Depression. Washington Post, January 11, 2002; Page A02. http://www.washingtonpost.com/ac2/2p-dyn/A28188-2002Jan10
  174. O’Donnell, JT. The Incidence of Bronchospasm or Asthma Following Non-depolarizing Muscle Relaxants on Adverse Events Reported to the Food and Drug Administration. Abstract. American Society of Anesthesiology Annual Meeting, October, 2002.
  175. (Interviewed for) Politzer B. Pharmacy Malpractice for a New Millennium. Pharmacy Practice News. October, 2002.
  176. A Primer for Avoiding Catastrophic Compounding Errors. Pharmacy Practice News, November, 2002, p. 16.
  177. (Gentamicin Vestibulopathy) Irreversible Mistakes Leave Lasting Scars. Pharmacy Practice News. December, 2002.
  178. Decimal Point and Dilution Errors Bring Pharmacists to Court. Pharmacy Practice News. January, 2003.
  179. Transcription Errors Trigger Addisonian Crisis: Pharmacy Practice News, February, 2003.
  180. Methotrexate not for daily dispensation-Errors and Toxicities Involving Pharmacists. Pharmacy Practice News, March, 2003.
  181. Overview of Existing Research and Information Linking Accutane (Isotretinoin), Depression, Psychosis and Suicide." American Journal of Therapeutics, Vol 10, Number 2, March/April 2003, 148-159.
  182. Anticoagulant Errors Spell Legal Trouble for Pharmacists. Pharmacy Practice News, May, 2003. p. 18.
  183. It Takes Your Breath Away. B-Blocker Use in Asthmatics Leads to Patient Injuries and Pharmacist Lawsuits. Pharmacy Practice News, June, 2003. . 31,34.
  184. Cross-Reactive Drugs Pose Anaphylaxis Risk. Pharmacy Practice News, June, 2003. p. 31,34.
  185. Fluoroquinolone Interactions Force Pharmacists into Court. Pharmacy Practice News, July, 2003.
  186. O’Donnell, JT. The Incidence of Bronchospasm or Asthma Following Non-depolarizing Muscle Relaxants on Adverse Events Reported to the Food and Drug Administration. Anesthesia and Analgesia, Vol 97, No. 2, 484-5. August, 2003.
  187. Calcium Phosphate Precipitates Legal Problems for Hospital Pharmacists. Pharmacy Practice News. August, 2003, pp32,34.
  188. Controlled Substance create legal problems for Pharmacists. Pharmacy Practice News. September, 2003, September, 2003, pp 14-15.
  189. Counseling Patients Can Prevent Pregnancy Exposure and Injury and Lawsuits Against Pharmacists. Pharmacy Practice News. October, 2003.
  190. Expert Opinion Helpful in Urine Drug Testing Cases. St. Louis Daily Record, Supplement, October, 2003, 4EW.
  191. Pill-Splitting leads to Renal Failure and Legal Trouble. Pharmacy Practice News. November, 2003.
  192. Pharmacists Get Burned by Acid Cases. Pharmacy Practice News. December, 2003.
  193. System Failure: Analysis of a Vincristine Intrathecal Paralysis Case. Pharmacy Practice News. January 2004.
  194. Pharmacists Get Burned by Acid Cases. LNC Resource. Vol 1, No. 1, January, 2004, p.4.
  195. PPA Plagues Pharmacists, Even While Pending Withdrawal.. Pharmacy Practice News. February 2004, 3, 5.
  196. Transcription Errors Trigger Addisonian Crisis: LNC Resource Vol 1, No. 2, February, 2004, p. 22.
  197. Gentamicin Vestibulopathy - Irreversible Mistakes Leave Lasting Scars. Rx Ipsa Loquitur, Vol 31 No 1, Jan / February 2004.
  198. Pre-packs Lead to Patient Deaths and Legal Nightmares for Pharmacists Pharmacy Practice News. March 2004.
  199. Systems Failure in Oncology Drug Administration: Intrathecal Vincristine Leads to Permanent Paralysis. Abstract for Poster Presentation. American College of Legal Medicine. March, 2004.
  200. Little Helpers that Hurt (Interviewed for). OTC Analgesics’ Toxicity. http:/ccd/fitdv.com/new/articles/article.;html?artid=264. Your Health: March Issue, March, 2004.
  201. O’Donnell JT**. Proceedings Abstract. The Incidence of Bronchospasm or Asthma Following Non-depolarizing Muscle Relaxants on Adverse Events Reported to the Food and Drug Administration. University of Illinois College of Medicine-Rockford , March 31, 2004
  202. Medication Issues: When Cross-Allergic Reactions Occur. LNC Resource, April 2004, Vol 1, No. 5, p.11.
  203. Daily CeeNU administration leads to Patient Toxicity and Legal Troubles for Pharmacists. Pharmacy Practice News, April, 2004.
  204. Drug Interactions Force Pharmacists Into Court. LNC Resource, Vol 1, No. 4 May 2004, p. 21.
  205. Drug Use - A Mitigating Factor in Criminal Cases. LNC Resource, Vol 1, No. 6, June, 2004, p. 15.
  206. New JCAHO IV Goal Could Burden Small Pharmacies. (Interviewed for) Hospital Pharmacy Regulation Report. hcPro Vol 2, N0. 6, June 2004.
  207. Scope of Practice. Pharmacy Practice News. July 2004.
  208. Pharmacists Get Burned by Acid. Rx Ipsa Loquitur, Vol 31 No 3,July / August 2004.
  209. System Failure - An Intrathecal Vincristine Tragedy. LNC Resource. August, 2004.Vol. 1, No. 8., P. 31.
  210. Use Literature to Support Off-Label Drug Scripts (Interviewed for). Hospital Pharmacy Regulation Report. HCPro,Vl 2, No. 8. August 2004, Page 6.
  211. Bishop MJ, O’Donnell JT, Bhananker SM, Salemi JR. Does Adverse Event Reporting Support An Increased Incidence of Anaphylaxis with Rocuronium. J Clin Pharmacology. 2004 :44:1185-1213.(abstract)
  212. From the Courtroom: Check, Don’t Assume, to Avoid Errors (Heparin Death in Home Care Patient related to Pharmacists Negligence). Pharmacy Practice News, October, 2004
  213. Missed Aminoglycoside Toxicity = Professional Incompetence.(Letter to Editor) Pharmacy Practice News. October, 2004.
  214. Scope of Practice. LNC RESOURCE. Vol. 1. No. 11. November 2004
  215. Systems Failure: An Intrathecal Vincristine Tragedy. Rx Ipsa Loquitur. Vol 31, No. 5, November/December, 2004.
  216. Polar Hysteria: An Expression of Hypervitaminosis A. American Journal of Therapeutics. 11, 507-516(2004).
  217. Drug Withdrawal Leads to Patient Injury and Legal Trouble. Pharmacy Practice News. November, 2004
  218. Pill Splitting Leads to Rhabdomyolysis & Renal Failure LNC Resource Vol 1, NO. 12, p. 19, December, 2004.
  219. (Interviewed for) FDA Urges Doctors to Limit Prescriptions for Two (Cox II Inhibitor) Painkillers
    By Harris G and Berenson A http://www.nytimes.com/2004/12/24/politics/24fda.html?ex=1105092990&ei=1&en=959606c7daafcdce December 24, 2004.
  220. Vigilance and Counseling Help Prevent Childbirth Tragedies. LNC Resource Vol 2, No.1 p. 12, January, 2005.
  221. Calcium Phosphate Precipitates Liability. LNC Resources. Vol. 2, No. 2. February, 2005. P. 7.
  222. Benjamin D and O’Donnell JT. Prothrombotic Effects of COX-2 Inhibitors. Is it a Class Effect?. Abstract. American College of Legal Medicine Annual Meeting Proceedings, p 545. March, 2005. 
  223. Vioxx (Rofecoxib) Market Withdrawal - Are There Legal Troubles in Sight for Pharmacists? Rx Ipsa Loquitur. Vol 32, No. 2, March/April 2005.
  224. Lets Stop Our Biggest Drug Problem - Alcohol Abuse. Newsletter of the Louisiana Criminal Defense Lawyers. April, 2005.
  225. Lets Stop Our Biggest Drug Problem - Alcohol Abuse. Newsletter of the Michigan Criminal Defense Lawyers. Volume 12, Number 1, Spring, 2005.
  226. Lets Stop Our Biggest Drug Problem - Alcohol Abuse. Newsletter of the Maine Criminal Defense Lawyers. April, 2005.
  227. Lets Stop Our Biggest Drug Problem - Alcohol Abuse. Newsletter of the Tennessee Criminal Defense Lawyers. Nashville, TN. May, 2005.
  228. Pharmacist Incomplete Chart Review Contributes to Myxedema Coma. LNC Resource. May, 2005, p. 11.
  229. From the Courtroom: More Than Just a Number: Looking Beyond the Med Sheet Bolsters Patient Safety. Pharmacy Practice News, May 2005. 40 - 41. 
  230. Lets Stop Our Biggest Drug Problem - Alcohol Abuse. The Advocate. Louisiana Association of Criminal Defense Layers. Volume 1, No. 4, Spring, 2005.
  231. The Role of Alcohol Abuse in DUI Cases. IACDL Newsletter. (Illinois Association of Criminal Defense Lawyers). Volume 2, Number 1, Spring 2005. 12 - 20.
  232. Lets Stop Our Biggest Drug Problem - Alcohol Abuse. Newsletter of the Alabama Criminal Defense Lawyers. June, 2005.
  233. Methylene blue injures spine patient and creates legal problems for pharmacist and hospital. LNC Resource. July, 2005.
  234. From the Courtroom: Methylene blue injures spine patient and creates legal problems for pharmacist and hospital. Pharmacy Practice News. July 2005.
  235. BOOK EDITOR. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  236. Chapter 3. The Pharmaceutical Industry. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  237. Chapter 9: Adverse Drug Reactions: The Extent of the Problem. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  238. Chapter 12: Medications Errors and Adverse Drug Reactions in Hospitalized Patients: How Common Are They, and Why Do They Occur? In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  239. Chapter 13: Medical-Legal Aspects of Medication Errors. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  240. Chapter 14: Preventing Medication Errors. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  241. Chapter 18: Diet Drugs: Pharmacology/Interactions/Cautions. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  242. Chapter 23: Corticosteroids. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  243. Chapter 24: Adverse Effects of Diabetic Drugs. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  244. Chapter 26: Drug-Induced Hepatotoxicity. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  245. Chapter 30: Pain Medications and OxyContin. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  246. Chapter 31: Performance-Enhancing Substances: Ephedrine, Anabolic Steroids, Herbals and Dietary Supplements. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  247. Chapter 32: Ephedra. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  248. Chapter 33: Recreational Drugs: Alcohol, Cocaine and Marijuana: Forensic Issues. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  249. Chapter 36: Pharmacist Malpractice and the Infamous Courtney Case. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  250. Chapter 42: The Forensic Pharmacist. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  251. Chapter 47: The NABP Model Act and Rules Initiative Toward Pharmacy Technicians. In O’Donnell JT, Ed. Drug Injury: Liability, Analysis, and Prevention. Second Edition. Lawyers & Judges Publishing Company, Tucson, AZ., 2005.
  252. Bishop MJ, O’Donnell JT, Bhananker SM, Salemi JR. Does Adverse Event Reporting Support An Increased Incidence of Anaphylaxis with Rocuronium. Anesthesia & Analgesia, September, 2005.
  253. (Interviewed for) Trebelcock B. Not What the Doctor Ordered. Good Housekeeping. June 2005.
  254. O’Donnell JT. Pharmacist Practice and Liability. J Nursing Law, Volume 10, Number 4, 2005, pp 201 -207.
  255. BOOK. Editor. Smith CG and O’Donnell JT. The Process of New Drug Discovery and Development. Taylor and Francis, Boca Raton. June, 2006, In Press.
  256. CHAPTER. Smith CG and O’Donnell JT. Overview of New Drug Discovery and Development. In Smith CG and O’Donnell JT, Eds. The Process of New Drug Discovery and Development. Informa Healthcare. July, 2006.
  257. CHAPTER. O’Donnell JT. Liability, Litigation, and Lessons in New Drug Development. In Smith CG and O’Donnell JT, Eds. The Process of New Drug Discovery and Development. Taylor and Francis, Boca Raton. July, 2006.
  258. CHAPTER Iyer P, O’Donnell JT, Benjamin DM. Medication Errors, In Iyer P, Ed. Nursing Malpractice, 3rd Ed. L&J Publishing, Tucson AZ, In Press.
  259. O’Donnell JT. Editorial. Pharmacists Need to Do the Right Thing. http://www.medicalaccountability.net/Articles_jodonnell.html , July, 2006.
  260.  Lass N and O’Donnell JT. Clinical Research Risks and the Importance of Life-Cycle Assessments. Update: Food and Drugs Law, Regulation and Education, September, 2006.
  261.  O’Donnell JT. Pharmacist Practice and Liability. NY State J Hosp Pharm., 2007, In Press
  262. O’Donnell JT. System Failure: Analysis of a Vincristine Intrathecal Paralysis Case. NY J Hosp Pharm.  2007 In Press.
  263.  O’Donnell JT.From the Courtroom: Check, Don’t Assume, to Avoid Errors (Heparin Death in Home  Care Patient related to Pharmacists Negligence) NY J Hosp Pharm,  2007. In Press.
  264.  Benjamin DM and O’Donnell JT. Medication Errors, in, Legal Medicine, 7th Edition, American College of Legal Medicine, 2007, In Press.
  265. O’Donnell JT and Benjamin DM. Pharmacist Malpractice, In Legal Medicine, 7th Edition, 2007, In Press.
  266.  O’Donnell JT. Caveats on Methadone for Pain Relief. Pharmacy Practice News, January,  2007.(Letter to the Editor).
  267.  Interviewed for Hurley D. $500K Award in Lomustine (CCNU) Death Underscores Chemo Risk. Pharmacy Practice News, April 2007, p. 46.
  268. Cisapride Risk for Fainting. Trial Testimony, State of Alaska v. Darling. Dateline NBC. June, 2007.

 Revised July 9, 2007 

 

[Home] [Order Books] [Curriculum Vitae] [Contact Us]  [Downloads] [Resources]